ATLASAgomAb Therapeutics NV (AGMB) earnings date and history
AgomAb Therapeutics NV (AGMB) has not announced its next earnings date yet.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on AGMB
| Last price | $6.94 (-7.3%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.5% |
These figures come from the same calibrated model and valuation as the AgomAb Therapeutics NV stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
The date is not announced yet; we will email you as soon as it is close. One email the day before, with ATLAS’s read on AgomAb Therapeutics NV. You can switch it off at any time.
Alert me before AGMB reportsFree to start. Creating an account takes under a minute.
Notify me when AgomAb Therapeutics NV reports
Track AGMB free Add AgomAb Therapeutics NV to a free ATLAS watchlist and see its next report date in one place.
AGMB earnings at a glance
| Next report | Not announced |
|---|---|
| Last report | Apr 16, 2026 · In line |
| Average EPS surprise | 0.0% |
| Sector | Healthcare · Biotechnology |
AgomAb Therapeutics NV earnings history: last 1 reports
AgomAb Therapeutics NV last reported on Apr 16, 2026: EPS of $1.15 against an estimate of $1.15 (0.0% surprise), in line with the estimate.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Apr 16, 2026 | $1.15 | $1.15 | 0.0% | In line | +6.3% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for AGMB
See the fair value, the probability range and the earnings history of AgomAb Therapeutics NV on its ATLAS page.
AgomAb Therapeutics NV (AGMB) stock analysisPlans from €3.99 a month.
AgomAb Therapeutics NV earnings: frequently asked questions
When is AgomAb Therapeutics NV (AGMB) next earnings date?
AgomAb Therapeutics NV has not announced its next report date and there is not enough history to estimate one.
Did AgomAb Therapeutics NV beat earnings estimates last quarter?
AgomAb Therapeutics NV last reported on Apr 16, 2026: EPS of $1.15 against an estimate of $1.15 (0.0% surprise), in line with the estimate.
How much does AGMB usually move in a day?
On a normal trading day the ATLAS model puts AGMB’s one-day range at about ±4.5%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Educational information, not investment advice. Disclaimer